M. J. Divo, C. Casanova, J. M. Marin, V. M. Pinto-plata, J. P. De-torres et al., COPD comorbidities network, Eur Respir J, vol.46, issue.3, pp.640-50, 2015.

W. Chen, J. Thomas, M. Sadatsafavi, and J. M. Fitzgerald, Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis, Lancet Respir Med, vol.3, issue.8, pp.241-247, 2015.

H. Müllerova, A. Agusti, S. Erqou, and D. W. Mapel, Cardiovascular comorbidity in COPD: systematic literature review, Chest, vol.144, issue.4, pp.1163-78, 2013.

A. E. Mirrakhimov, Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony, Cardiovasc Diabetol, vol.11, p.132, 2012.

E. Wouters, Obesity and Metabolic Abnormalities in Chronic Obstructive Pulmonary Disease, Ann Am Thorac Soc, vol.14, issue.Supplement_5, pp.389-94, 2017.

C. Lipovec, N. Beijers, R. Van-den-borst, B. Doehner, W. Lainscak et al., The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review, COPD, vol.13, issue.3, pp.399-406, 2016.

M. Breyer, M. A. Spruit, C. K. Hanson, F. Franssen, L. Vanfleteren et al., Prevalence of metabolic syndrome in COPD patients and its consequences, PLoS ONE, vol.9, issue.6, p.98013, 2014.

J. C. Jun, M. Shin, Q. Yao, S. Bevans-fonti, J. Poole et al., Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice, Am J Physiol Endocrinol Metab, vol.303, issue.3, pp.377-388, 2012.

L. Xuan, F. Han, L. Gong, Y. Lv, Z. Wan et al., Association between chronic obstructive pulmonary disease and serum lipid levels: a meta-analysis, Lipids Health Dis, vol.17, issue.1, p.30463568, 2018.

A. Plihalova, H. Bartakova, M. Vasakova, S. Gulati, I. Deglisezinski et al., The effect of hypoxia and re-oxygenation on adipose tissue lipolysis in COPD patients, Eur Respir J, vol.48, issue.4, pp.1218-1238, 2016.

J. Ye, Emerging role of adipose tissue hypoxia in obesity and insulin resistance, Int J Obes (Lond), vol.33, issue.1, pp.54-66, 2009.

B. Van-den-borst, A. Schols, C. De-theije, A. W. Boots, S. E. Köhler et al., Characterization of the inflammatory and metabolic profile of adipose tissue in a mouse model of chronic hypoxia, J Appl Physiol, vol.114, issue.11, pp.1619-1647, 2013.

N. Leone, D. Courbon, F. Thomas, K. Bean, B. Jé-go et al., Lung function impairment and metabolic syndrome: the critical role of abdominal obesity, Am J Respir Crit Care Med, vol.179, issue.6, pp.509-525, 2009.

L. Vanfleteren, A. Van-meerendonk, F. M. Franssen, E. Wouters, F. M. Mottaghy et al., A possible link between increased metabolic activity of fat tissue and aortic wall inflammation in subjects with COPD. A retrospective 18F-FDG-PET/CT pilot study, Respir Med, vol.108, issue.6, pp.883-90, 2014.

L. Vanfleteren, M. A. Spruit, M. Groenen, P. Bruijnzeel, and E. Taib-z-rutten, Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation, Eur Respir J, vol.43, issue.5, pp.1306-1321, 2014.

R. Kahn, J. Buse, E. Ferrannini, and M. Stern, The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care, vol.28, issue.9, pp.2289-304, 2005.

P. Burgel, J. Paillasseur, B. Peene, D. Dusser, N. Roche et al., Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality, PLoS ONE, vol.7, issue.12, p.51048, 2012.

S. I. Rennard, N. Locantore, B. Delafont, R. Tal-singer, E. K. Silverman et al., Identification of Five Chronic Obstructive Pulmonary Disease Subgroups with Different Prognoses in the ECLIPSE Cohort Using Cluster Analysis, vol.12, pp.303-315, 2015.

J. Garcia-aymerich, F. P. Gómez, M. Benet, E. Farrero, X. Basagaña et al., Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax, vol.66, pp.430-437, 2011.

L. Vanfleteren, M. A. Spruit, M. Groenen, S. Gaffron, V. Van-empel et al., Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.187, issue.7, pp.728-763, 2013.

V. Coats, N. Despré-s-j-p,-almé-ras, M. Martin, D. D. Sin, and R. Rabasa-lhoret, Ectopic adiposity and cardiometabolic health in COPD, Int J Chron Obstruct Pulmon Dis, vol.13, pp.3331-3371, 2018.

P. Gayoso-diz, A. Otero-gonzá-lez, M. X. Rodriguez-alvarez, F. Gude, F. García et al., Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study, BMC Endocr Disord, vol.13, p.47, 2013.

Z. Radikova, J. Koska, M. Huckova, L. Ksinantova, R. Imrich et al., Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects, Exp Clin Endocrinol Diabetes, vol.114, issue.5, pp.249-56, 2006.

H. Qu, Q. Li, A. R. Rentfro, S. P. Fisher-hoch, and J. B. Mccormick, The Definition of Insulin Resistance Using HOMA-IR for Americans of Mexican Descent Using Machine Learning, PLoS One, vol.6, issue.6, p.21041, 2011.

C. Yamada, T. Mitsuhashi, N. Hiratsuka, F. Inabe, N. Araida et al., Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population, J Diabetes Investig, vol.2, issue.5, p.24843516, 2011.

M. K. Rutter, P. Wilson, L. M. Sullivan, C. S. Fox, D. 'agostino et al., Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease, vol.117, pp.1003-1012, 2008.

M. B. Elshazly, S. J. Nicholls, S. E. Nissen, J. St-john, S. S. Martin et al., Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events, Am J Cardiol, vol.118, issue.5, pp.647-55, 2016.

J. Després and I. Lemieux, Abdominal obesity and metabolic syndrome, Nature, vol.444, issue.7121, pp.881-888, 2006.

J. Després, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu et al., Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk, Arterioscler Thromb Vasc Biol, vol.28, issue.6, pp.1039-1088, 2008.

J. Bourbeau, W. C. Tan, A. Benedetti, S. D. Aaron, K. R. Chapman et al., Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD, COPD, vol.11, issue.2, pp.125-157, 2014.

M. Shorofsky, J. Bourbeau, J. Kimoff, J. R. Malhotra, A. Ayas et al., Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort Study. Chest, vol.156, pp.852-63, 2019.

M. Martin, N. Almeras, C. Despré-s-j-p, . Ho, G. R. Washko et al., Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy, Int J Chron Obstruct Pulmon Dis, vol.12, pp.451-60, 2017.

M. Bastien, P. Poirier, P. Brassard, B. J. Arsenault, O. F. Bertrand et al., Effect of PPAR? agonist on aerobic exercise capacity in relation to body fat distribution in men with type 2 diabetes mellitus and coronary artery disease: a 1-yr randomized study, Am J Physiol Endocrinol Metab, vol.01, issue.1, pp.65-73, 2018.

B. Antuna-puente, E. Disse, R. Rabasa-lhoret, M. Laville, J. Capeau et al., How can we measure insulin sensitivity/resistance?, Diabetes Metab, vol.37, issue.3, pp.179-88, 2011.

A. L. Catapano, I. Graham, D. Backer, G. Wiklund, O. Chapman et al., ESC/EAS Guidelines for the Management of Dyslipidaemias, Eur Heart J, vol.37, issue.39, pp.2999-3058, 2016.

D. M. Mannino, R. C. Gagnon, T. L. Petty, and E. Lydick, Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994, Arch Intern Med, vol.160, issue.11, pp.1683-1692, 2000.

W. C. Tan, C. J. Hague, J. Leipsic, J. Bourbeau, L. Zheng et al., Findings on Thoracic Computed Tomography Scans and Respiratory Outcomes in Persons with and without Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study, PLoS One, vol.11, issue.11, p.166745, 2016.

C. W. Baffi, L. Wood, D. Winnica, P. J. Strollo, M. T. Gladwin et al., Metabolic Syndrome and the Lung, Chest, vol.149, issue.6, pp.1525-1559, 2016.

A. Dimoulis, C. Pastaka, V. Tsolaki, I. Tsilioni, S. Pournaras et al., Non-Invasive Ventilation (NIV) and Homeostatic Model Assessment (HOMA) Index in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients with Chronic Hypercapnic Respiratory Failure: A Pilot Study, COPD, vol.12, issue.4, pp.427-461, 2015.

C. E. Bolton, M. Evans, A. A. Ionescu, S. M. Edwards, R. Morris et al., Insulin resistance and inflammation-A further systemic complication of COPD, COPD, vol.4, issue.2, pp.121-127, 2007.

F. Machado, F. Pitta, N. A. Hernandes, and G. L. Bertolini, Physiopathological relationship between chronic obstructive pulmonary disease and insulin resistance, Endocrine, vol.61, issue.1, p.29512058, 2018.

O. Sideleva, B. T. Suratt, K. E. Black, W. G. Tharp, R. E. Pratley et al., Obesity and asthma: an inflammatory disease of adipose tissue not the airway, Am J Respir Crit Care Med, vol.186, issue.7, pp.598-605, 2012.

E. Forno, Y. Han, R. H. Muzumdar, and J. C. Celedó-n, Insulin resistance, metabolic syndrome, and lung function in US adolescents with and without asthma, J Allergy Clin Immunol, vol.136, issue.2, pp.304-311, 2015.

Z. Nie, D. B. Jacoby, and A. D. Fryer, Hyperinsulinemia potentiates airway responsiveness to parasympathetic nerve stimulation in obese rats, Am J Respir Cell Mol Biol, vol.51, issue.2, pp.251-61, 2014.

W. Lin, C. Yao, H. Wang, and K. Huang, Impaired lung function is associated with obesity and metabolic syndrome in adults, Obesity (Silver Spring), vol.14, issue.9, pp.1654-61, 2006.

K. Nakajima, Y. Kubouchi, T. Muneyuki, M. Ebata, S. Eguchi et al., A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome, Chest, vol.134, issue.4, pp.712-720, 2008.

L. E. Vanfleteren, B. Lamprecht, M. Studnicka, B. Kaiser, L. Gnatiuc et al., Body mass index and chronic airflow limitation in a worldwide population-based study, Chron Respir Dis, vol.13, issue.2, pp.90-101, 2016.

N. T. Vozoris, D. E. O'donnell, and . Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease, Can Respir J, vol.19, issue.3, pp.18-24, 2012.

L. Steuten, E. C. Creutzberg, H. Vrijhoef, and E. F. Wouters, COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care, Prim Care Respir J, vol.15, issue.2, pp.84-91, 2006.

E. Rutten, P. Calverley, R. Casaburi, A. Agusti, P. Bakke et al., Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes?, Ann Nutr Metab, vol.63, issue.3, pp.239-286, 2013.

L. E. Labonté, W. C. Tan, P. Z. Li, P. Mancino, S. D. Aaron et al., Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study

, Am J Respir Crit Care Med, vol.01, issue.3, pp.285-98, 2016.

C. H. Martinez, D. M. Mannino, F. A. Jaimes, J. L. Curtis, M. K. Han et al., Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality, Ann Am Thorac Soc. dé c, vol.12, issue.12, pp.1788-95, 2015.